Literature DB >> 3622581

Calcium channel blockers and essential tremor.

S Topaktas, R Onur, T Dalkara.   

Abstract

Acute effects of two calcium blockers, nifedipine and verapamil, were investigated on the tremor activity of 8 patients with essential tremor and compared with those of propranolol and placebo. Following a single oral dose of 10 mg of nifedipine, tremor intensity of the patients was increased by 71.4 +/- 22.6%. Nifedipine also enhanced physiological tremor in 6 healthy volunteers by 56.0 +/- 21.9%. This effect of nifedipine was not correlated with the increase in heart rate or decrease in systemic blood pressure. Verapamil (80 mg) did not appreciably alter the patients' tremor activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622581     DOI: 10.1159/000116142

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  7 in total

1.  T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor.

Authors:  Adrian Handforth; Gregg E Homanics; Douglas F Covey; Kathiresan Krishnan; Jae Yeol Lee; Kenji Sakimura; Fredricka C Martin; Arnulfo Quesada
Journal:  Neuropharmacology       Date:  2010-06-12       Impact factor: 5.250

Review 2.  Pharmacological management of essential tremor.

Authors:  Reza Sadeghi; William G Ondo
Journal:  Drugs       Date:  2010-12-03       Impact factor: 9.546

Review 3.  Benefits and risks of pharmacological treatments for essential tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa; Cynthia L Comella; Mahmood S Eisa; Rodger J Elble; Stanley Fahn; Joseph Jankovic; Jorge L Juncos; William C Koller; William G Ondo; Kapil D Sethi; Matthew B Stern; Caroline M Tanner; Ron Tintner; Ray L Watts
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

4.  Overview of essential tremor.

Authors:  Theresa A Zesiewicz; Abinaya Chari; Israt Jahan; Amber M Miller; Kelly L Sullivan
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

5.  Central effects of the calcium antagonist, nifedipine.

Authors:  D G McDevitt; D Currie; A N Nicholson; N A Wright; M B Zetlein
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

Review 6.  Pharmacotherapy of essential tremor.

Authors:  Peter Hedera; František Cibulčík; Thomas L Davis
Journal:  J Cent Nerv Syst Dis       Date:  2013-12-22

Review 7.  Current and Future Neuropharmacological Options for the Treatment of Essential Tremor.

Authors:  Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez; Félix J Jiménez-Jiménez
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.